Showing results (291-300 of 758) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|December 4, 2018
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensusRebecca Fish, Caroline Sanders, Richard Adams, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2018
Effects of enteral nutrition on gastrointestinal function in patients who are critically illMichael Schörghuber, Sonja Fruhwald
The Lancet. Gastroenterology & Hepatology|March 18, 2020
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Gastroenterology & Hepatology|March 21, 2020
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage studyMingyang Song, Louise Emilsson, Soran R Bozorg, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
Personalised medicine in Crohn's diseaseNurulamin M Noor, Bram Verstockt, Miles Parkes, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2020
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled studyYing-Xuan Chen, Qin-Yan Gao, Tian-Hui Zou, et al.
The Lancet. Gastroenterology & Hepatology|March 15, 2020
Small molecule oral targeted therapies in ulcerative colitisUday N Shivaji, Olga Maria Nardone, Rosanna Cannatelli, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2020
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trialRaja Atreya, Laurent Peyrin-Biroulet, Andrii Klymenko, et al.
The Lancet. Gastroenterology & Hepatology|January 17, 2019
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology CommissionGraham S Cooke, Isabelle Andrieux-Meyer, Tanya L Applegate, et al.
Pageof 76